<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T00:47:29Z</responseDate>
  <request identifier="oai:figshare.com:article/32639550" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32639550</identifier>
        <datestamp>2026-10-01T16:39:10Z</datestamp>
        <setSpec>portal_1172</setSpec>
        <setSpec>item_type_8</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Discovery and evaluation of trypsin inhibitor peptides and analogues from Schmacker’s frog, Odorrana schmackeri</dc:title>
          <dc:creator>Ying Wang (11406)</dc:creator>
          <dc:subject>PUREID: 588617785</dc:subject>
          <dc:description>As the risks posed by cancer and antibiotic-resistant bacteria to human health keep rising,
extensive research has been dedicated to bioactive peptides. These peptides can trigger
different physiological responses due to their remarkable specificity and affinity to cell surface
receptors. The various biological and pharmaceutical functions of peptides present a wealth of
opportunities, rendering them as promising candidates for therapeutic development.
In this research, a novel peptide belonging to the Bowman-Birk type inhibitor (BBI) family, was
isolated and identified from the skin secretion of the frog, Odorrana schmackeri. The
biofunctionality was studied and several analogues were generated by rational structural
modifications to the parent peptide for optimizing the antimicrobial or anticancer activities. Then,
several strategies were used to modify a second type of trypsin inhibitor peptide to validate the
rationale and effectiveness of the structural modification strategies. However, they all exerted a
toxicity to normal cells (HaCaT). In conclusion, when TIL was conjugated with TAT, the
biological functions were improved greatly especially on the antimicrobial activity, in addition,
the residues linker (-GG-) seems to play an important promotion in the improvement of
biological activities especially in the anticancer cell proliferation. Finally, the conjugation of cell
penetrating peptides (CPPs) offers a compelling indication for exploring novel applications,
suggesting potential avenues for peptide drug development. &lt;br&gt;&lt;i&gt;&lt;br&gt;Thesis is embargoed until 31 July 2029.&lt;/i&gt;</dc:description>
          <dc:date>2026-10-01T16:39:10Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Thesis</dc:type>
          <dc:identifier>10.17034/32639550.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/thesis/Discovery_and_evaluation_of_trypsin_inhibitor_peptides_and_analogues_from_Schmacker_s_frog_Odorrana_schmackeri/32639550</dc:relation>
          <dc:rights>All Rights Reserved</dc:rights>
          <dc:rights>Open Access after 2029-07-31</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
